This brand name is authorized in Netherlands
The drug LOCASALENΕ contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Flumetasone
UNII 0DV09X6F21 - FLUMETHASONE PIVALATE
|
|
|
|
2
Salicylic acid
UNII O414PZ4LPZ - SALICYLIC ACID
|
|
Salicylic acid has bacteriostatic and fungicidal actions, but it is its keratolytic properties which are important for this medicinal product. When applied externally it produces slow and painless destruction of the epithelium. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| D07BB01 | Flumetasone and antiseptics | D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07B Corticosteroids, combinations with antiseptics → D07BB Corticosteroids, moderately potent, combinations with antiseptics |
| D07XB01 | Flumetasone | D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07X Corticosteroids, other combinations → D07XB Corticosteroids, moderately potent, other combinations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: NL | Z-Index G-Standaard | Identifier(s): 13965085 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 6467 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
